MATTHEW BRUNO: Open Payments
NPI 1194861849 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216,153 in 705 payments from 27 companies in 2025. Trend: 2023 $95,622 · 2024 $183,927 · 2025 $216,153
Speaker / faculty: $99,030Honoraria: $45,300Consulting: $29,361Travel & lodging: $27,254Food & beverage: $14,915Education: $294
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 112 | $61,486 |
| Regeneron Healthcare Solutions, Inc. | 90 | $40,319 |
| UCB, Inc. | 88 | $38,758 |
| ABBVIE INC. | 79 | $18,112 |
| Amgen Inc. | 48 | $15,844 |
| Galderma Laboratories, L.P. | 37 | $8,381 |
| GENZYME CORPORATION | 26 | $8,311 |
| Lilly USA, LLC | 18 | $3,894 |
| Arcutis Biotherapeutics, Inc. | 30 | $3,315 |
| LEO Pharma Inc. | 32 | $2,335 |
Products named: VTAMA, DUPIXENT, Bimzelx, Otezla, SKYRIZI, NEMLUVIO, RINVOQ, Zoryve.
Industry payments across TX — which companies pay providers there.
